Syra Health (SYRA) Competitors

$0.45 +0.04 (+8.93%)

As of 01:46 PM Eastern

SYRA vs. SWVL, GRNQ, YMT, ZGM, and MGIH

Should you be buying Syra Health stock or one of its competitors? The main competitors of Syra Health include Swvl (SWVL), Greenpro Capital (GRNQ), Yimutian (YMT), Zenta Group (ZGM), and Millennium Group International (MGIH). These companies are all part of the "business services" industry.

How does Syra Health compare to Swvl?

Syra Health (NASDAQ:SYRA) and Swvl (NASDAQ:SWVL) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Syra Health
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Swvl
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: In the previous week, Syra Health had 1 more articles in the media than Swvl. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for Swvl. Syra Health's average media sentiment score of 0.00 equaled Swvl'saverage media sentiment score.
Company Overall Sentiment
Syra Health Neutral
Swvl Neutral
: 4.8% of Syra Health shares are held by institutional investors. Comparatively, 34.0% of Swvl shares are held by institutional investors. 24.6% of Syra Health shares are held by company insiders. Comparatively, 29.9% of Swvl shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
: Syra Health has a beta of 3.1, suggesting that its share price is 210% more volatile than the S&P 500. Comparatively, Swvl has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500.
: Swvl has higher revenue and earnings than Syra Health.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Syra Health $7.98M 0.63 -$2.94M -$0.08 N/A
Swvl $24.17M 0.75 $1.31M N/A N/A
: Swvl has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Swvl's return on equity of 0.00% beat Syra Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Syra Health -54.90% -131.94% -99.19%
Swvl N/A N/A N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Swvl	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Overall Sentiment
Syra Health	Neutral
Swvl	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syra Health	$7.98M	0.63	-$2.94M	-$0.08	N/A
Swvl	$24.17M	0.75	$1.31M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Syra Health	-54.90%	-131.94%	-99.19%
Swvl	N/A	N/A	N/A

Summary

Swvl beats Syra Health on 9 of the 11 factors compared between the two stocks.

How does Syra Health compare to Greenpro Capital?

Greenpro Capital (NASDAQ:GRNQ) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenpro Capital
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Syra Health
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: In the previous week, Greenpro Capital had 3 more articles in the media than Syra Health. MarketBeat recorded 4 mentions for Greenpro Capital and 1 mentions for Syra Health. Greenpro Capital's average media sentiment score of 1.13 beat Syra Health's score of 0.00 indicating that Greenpro Capital is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Greenpro Capital
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Syra Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Greenpro Capital has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Comparatively, Syra Health has a beta of 3.1, meaning that its share price is 210% more volatile than the S&P 500.
: 0.9% of Greenpro Capital shares are held by institutional investors. Comparatively, 4.8% of Syra Health shares are held by institutional investors. 39.7% of Greenpro Capital shares are held by insiders. Comparatively, 24.6% of Syra Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: Syra Health has higher revenue and earnings than Greenpro Capital. Greenpro Capital is trading at a lower price-to-earnings ratio than Syra Health, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Greenpro Capital $2.07M 10.24 -$2.98M -$0.37 N/A
Syra Health $7.98M 0.63 -$2.94M -$0.08 N/A
: Syra Health has a net margin of -54.90% compared to Greenpro Capital's net margin of -143.85%. Greenpro Capital's return on equity of -51.96% beat Syra Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Greenpro Capital -143.85% -51.96% -37.35%
Syra Health -54.90% -131.94% -99.19%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenpro Capital	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenpro Capital	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Syra Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenpro Capital	$2.07M	10.24	-$2.98M	-$0.37	N/A
Syra Health	$7.98M	0.63	-$2.94M	-$0.08	N/A

Company	Net Margins	Return on Equity	Return on Assets
Greenpro Capital	-143.85%	-51.96%	-37.35%
Syra Health	-54.90%	-131.94%	-99.19%

Summary

Greenpro Capital and Syra Health tied by winning 7 of the 14 factors compared between the two stocks.

How does Syra Health compare to Yimutian?

Yimutian (NASDAQ:YMT) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yimutian
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Syra Health
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: In the previous week, Yimutian had 3 more articles in the media than Syra Health. MarketBeat recorded 4 mentions for Yimutian and 1 mentions for Syra Health. Syra Health's average media sentiment score of 0.00 beat Yimutian's score of -0.33 indicating that Syra Health is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Yimutian
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Syra Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 4.8% of Syra Health shares are held by institutional investors. 24.6% of Syra Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: Yimutian has higher earnings, but lower revenue than Syra Health.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Yimutian N/A N/A N/A N/A N/A
Syra Health $7.98M 0.63 -$2.94M -$0.08 N/A
: Yimutian has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Yimutian's return on equity of 0.00% beat Syra Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Yimutian N/A N/A N/A
Syra Health -54.90% -131.94% -99.19%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yimutian	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Yimutian	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Syra Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yimutian	N/A	N/A	N/A	N/A	N/A
Syra Health	$7.98M	0.63	-$2.94M	-$0.08	N/A

Company	Net Margins	Return on Equity	Return on Assets
Yimutian	N/A	N/A	N/A
Syra Health	-54.90%	-131.94%	-99.19%

Summary

Yimutian beats Syra Health on 5 of the 9 factors compared between the two stocks.

How does Syra Health compare to Zenta Group?

Zenta Group (NASDAQ:ZGM) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

: Zenta Group has higher earnings, but lower revenue than Syra Health.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Zenta Group N/A N/A N/A N/A N/A
Syra Health $7.98M 0.63 -$2.94M -$0.08 N/A
: Zenta Group has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Zenta Group's return on equity of 0.00% beat Syra Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Zenta Group N/A N/A N/A
Syra Health -54.90% -131.94% -99.19%
: 4.8% of Syra Health shares are owned by institutional investors. 24.6% of Syra Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: In the previous week, Syra Health had 1 more articles in the media than Zenta Group. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for Zenta Group. Zenta Group's average media sentiment score of 0.00 equaled Syra Health'saverage media sentiment score.
Company Overall Sentiment
Zenta Group Neutral
Syra Health Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zenta Group
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Syra Health
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zenta Group	N/A	N/A	N/A	N/A	N/A
Syra Health	$7.98M	0.63	-$2.94M	-$0.08	N/A

Company	Net Margins	Return on Equity	Return on Assets
Zenta Group	N/A	N/A	N/A
Syra Health	-54.90%	-131.94%	-99.19%

Company	Overall Sentiment
Zenta Group	Neutral
Syra Health	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zenta Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Zenta Group and Syra Health tied by winning 4 of the 8 factors compared between the two stocks.

How does Syra Health compare to Millennium Group International?

Millennium Group International (NASDAQ:MGIH) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

: Syra Health has lower revenue, but higher earnings than Millennium Group International.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Millennium Group International $25.33M 0.68 -$6.32M N/A N/A
Syra Health $7.98M 0.63 -$2.94M -$0.08 N/A
: Millennium Group International has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Millennium Group International's return on equity of 0.00% beat Syra Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Millennium Group International N/A N/A N/A
Syra Health -54.90% -131.94% -99.19%
: 0.3% of Millennium Group International shares are owned by institutional investors. Comparatively, 4.8% of Syra Health shares are owned by institutional investors. 24.6% of Syra Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: In the previous week, Syra Health had 1 more articles in the media than Millennium Group International. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for Millennium Group International. Millennium Group International's average media sentiment score of 0.00 equaled Syra Health'saverage media sentiment score.
Company Overall Sentiment
Millennium Group International Neutral
Syra Health Neutral
: Millennium Group International has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, Syra Health has a beta of 3.1, meaning that its stock price is 210% more volatile than the S&P 500.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Millennium Group International
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Syra Health
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Millennium Group International	$25.33M	0.68	-$6.32M	N/A	N/A
Syra Health	$7.98M	0.63	-$2.94M	-$0.08	N/A

Company	Net Margins	Return on Equity	Return on Assets
Millennium Group International	N/A	N/A	N/A
Syra Health	-54.90%	-131.94%	-99.19%

Company	Overall Sentiment
Millennium Group International	Neutral
Syra Health	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Millennium Group International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Syra Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Millennium Group International beats Syra Health on 6 of the 11 factors compared between the two stocks.

Get Syra Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SYRA vs. The Competition

Export

Metric	Syra Health	Employment agencies Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.06M	$15.30M	$6.25B	$11.77B
Dividend Yield	N/A	N/A	2.74%	5.26%
P/E Ratio	-0.69	N/A	29.25	27.07
Price / Sales	0.63	0.45	504.68	73.47
Price / Cash	N/A	N/A	43.30	53.90
Price / Book	0.72	0.51	9.67	6.69
Net Income	-$2.94M	-$13.52M	$3.55B	$332.64M
7 Day Performance	5.33%	4.01%	1.70%	2.01%
1 Month Performance	86.71%	44.47%	5.62%	9.19%
1 Year Performance	N/A	28.70%	34.42%	39.59%

Syra Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SYRA Syra Health	N/A	$0.45 +8.9%	N/A	N/A	$5.06M	$7.98M	N/A	78	Upcoming Earnings
SWVL Swvl	0.3944 of 5 stars	$1.98 -2.0%	N/A	N/A	$20M	$24.17M	N/A	2	Positive News Gap Down
GRNQ Greenpro Capital	1.1606 of 5 stars	$2.54 +12.2%	N/A	N/A	$19.49M	$2.07M	N/A	60
YMT Yimutian	N/A	$0.17 +1.2%	N/A	N/A	$19.10M	N/A	N/A	573	Stock Split
ZGM Zenta Group	N/A	$1.62 -1.6%	N/A	N/A	$18.81M	N/A	N/A	9	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SYRA) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Syra Health (SYRA) Competitors

SYRA vs. SWVL, GRNQ, YMT, ZGM, and MGIH

How does Syra Health compare to Swvl?

Summary

How does Syra Health compare to Greenpro Capital?

Summary

How does Syra Health compare to Yimutian?

Summary

How does Syra Health compare to Zenta Group?

Summary

How does Syra Health compare to Millennium Group International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Syra Health (SYRA) Competitors

SYRA vs. SWVL, GRNQ, YMT, ZGM, and MGIH

How does Syra Health compare to Swvl?

Summary

How does Syra Health compare to Greenpro Capital?

Summary

How does Syra Health compare to Yimutian?

Summary

How does Syra Health compare to Zenta Group?

Summary

How does Syra Health compare to Millennium Group International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SYRA vs. The Competition

Syra Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools